分组1 - Interparfums reported quarterly earnings of $0.88 per share, exceeding the Zacks Consensus Estimate of $0.78 per share, and showing an increase from $0.82 per share a year ago, resulting in an earnings surprise of +12.82% [1] - The company achieved revenues of $386.18 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.07% and increasing from $361.5 million year-over-year [2] - Interparfums has outperformed the S&P 500, with shares rising approximately 19.9% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.18 on revenues of $345.44 million, and for the current fiscal year, it is $4.82 on revenues of $1.49 billion [7] - The Zacks Industry Rank indicates that the Consumer Products - Discretionary sector is in the bottom 42% of over 250 Zacks industries, suggesting that industry outlook can significantly impact stock performance [8]

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report fourth quarter and fiscal 2025 financial results before the market opens on Thursday, March 5, 2026. The company plans to host an investor conference call and webcast to review fourth quarter and fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) ...

Core Viewpoint - The financial community is evaluating the potential acquisition of Olaplex by Henkel AG, following a Bloomberg report about Henkel's takeover proposal for the New York-based hair care brand [1]. Group 1: Olaplex's Market Performance - Olaplex's stock has experienced a decline of over 90 percent since its public listing in September 2021, attributed to market-share losses and weak organic growth [2]. - Following the speculation of a takeover, Olaplex's stock rose by 22.2 percent, closing at $1.66, with a market capitalization of $1.09 billion [2]. - As of Thursday noon ET, Olaplex's stock was trading up 0.3 percent [2]. Group 2: Acquisition Details - The potential deal between Henkel and Olaplex could materialize within weeks, although its completion is not guaranteed [3]. - Advent International is reported to be Olaplex's largest shareholder, holding approximately a 75 percent stake [3]. Group 3: Strategic Implications for Henkel - Henkel aims to expand its presence in the hair care sector, reducing its reliance on home care products and enhancing its consumer division, which has undergone restructuring over the past three years [4]. - The acquisition of Olaplex could allow Henkel to leverage its global distribution channels more effectively, as international sales currently account for about 50 percent of Olaplex's net sales [5]. Group 4: Market Sentiment and Risks - Bernstein analysts express caution regarding the acquisition, citing Olaplex's specific challenges and Henkel's execution issues as potential risks [6]. - The beauty industry is anticipated to see increased M&A activity in 2026, following a rise in deals during 2025 [6].

Core Insights - Olaplex reported Q3 CY2025 revenue of $114.6 million, a 3.8% year-on-year decline, but exceeded analyst expectations of $109.9 million [1][6] - The company expects full-year revenue to be around $420.5 million, aligning with analyst estimates [1][6] - GAAP profit per share was $0.02, surpassing analysts' consensus of $0 [1][6] Revenue and Financial Performance - Revenue for Q3 was $114.6 million, reflecting a 3.8% decline year-on-year but a 4.2% beat against analyst estimates [6] - Adjusted EBITDA was $30.79 million, exceeding analyst estimates of $26.85 million, with a margin of 26.9% [6] - Operating margin decreased to 3.7% from 23.5% in the same quarter last year [6] - Market capitalization stands at $720.8 million [6] Strategic Initiatives - The company is undergoing a strategic shift towards coordinated marketing and product innovation, which is expected to improve sell-through trends [3][4] - Upcoming product launches and the acquisition of Purvala Bioscience are anticipated to enhance the R&D pipeline and support long-term growth [4] - Management emphasized the importance of brand investment and targeted international expansion as part of their growth strategy [4][5] Management Insights - Key factors influencing the quarter's results include coordinated product launches, brand-building efforts, and improved professional partnerships [5] - CEO Amanda Baldwin highlighted the company's focus on balancing immediate innovation with long-term strategic investments [4][5]

Core Insights - Olaplex's shares increased by 6.5% after reporting third-quarter results that exceeded Wall Street's expectations for revenue and earnings per share, while reaffirming its full-year guidance [1] - Despite a year-over-year decline in net sales by 3.8% to $114.6 million, the results surpassed analyst forecasts, and earnings per share remained flat at $0.02, also exceeding consensus estimates [1] - The company's decision to maintain its full-year sales forecast likely instilled confidence among investors, indicating a stable outlook despite the sales dip [1] Market Reaction - After an initial surge, Olaplex's shares settled at $1.10, reflecting a 2.3% increase from the previous close [2] - The stock has shown extreme volatility, with 42 moves greater than 5% over the past year, suggesting that the market views the recent news as significant but not fundamentally altering its perception of the business [3] Analyst Insights - A previous notable stock movement occurred when Telsey Advisory Group maintained a "Market Perform" rating while keeping a price target of $2.00, indicating a potential upside of 90.48% [4] - The gap between the current trading price and the analyst's valuation appears to be a key driver for the recent positive movement in the stock [4] Performance Overview - Olaplex's stock has declined by 35.2% since the beginning of the year and is currently trading 49.5% below its 52-week high of $2.17 from December 2024 [5] - An investment of $1,000 in Olaplex shares at the IPO in September 2021 would now be worth approximately $44.69 [5]

Core Viewpoint - Acco Brands reported quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.22 per share, and showing a decline from $0.23 per share a year ago, indicating a negative earnings surprise of -4.55% [1] Financial Performance - The company posted revenues of $383.7 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 1.88%, and down from $420.9 million year-over-year [2] - Over the last four quarters, Acco has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance - Acco shares have declined approximately 25.5% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.38 for the coming quarter and $0.86 for the current fiscal year, with revenues expected to be $431.75 million and $1.54 billion respectively [7] - The estimate revisions trend for Acco was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] Industry Context - The Consumer Products - Discretionary industry, to which Acco belongs, is currently in the bottom 28% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - Reynolds Consumer Products reported quarterly earnings of $0.42 per share, exceeding the Zacks Consensus Estimate of $0.39 per share, and showing a slight increase from $0.41 per share a year ago, resulting in an earnings surprise of +7.69% [1] - The company achieved revenues of $931 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.60% and reflecting a year-over-year increase from $910 million [2] - The stock has underperformed the market, losing approximately 12.2% since the beginning of the year, while the S&P 500 has gained 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.55 on revenues of $992.49 million, and for the current fiscal year, it is $1.57 on revenues of $3.65 billion [7] - The estimate revisions trend for Reynolds Consumer Products was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Consumer Products - Discretionary industry is currently ranked in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Industry Overview - The beauty industry is witnessing significant developments, including financial reports from various companies and the successful registration of new raw materials like Ursolic Acid [1] - Major brands are launching new products and entering new markets, indicating a dynamic and evolving landscape [1] Company Performance - Up Beauty reported a record revenue of 4.108 billion yuan for the first half of 2025, a year-on-year increase of 17.3%, with a net profit of 556 million yuan, up 34.7% [2] - Giant Biological achieved a revenue of 3.113 billion yuan in the first half of 2025, reflecting a 22.5% year-on-year growth, with a net profit of 1.182 billion yuan, up 20.6% [21] - Huaxi Biological reported a revenue of 2.261 billion yuan, with net profit figures showing no growth, but signs of strategic adjustments beginning to take effect [22] - Marubi Biological's revenue for the first half of 2025 reached 1.769 billion yuan, a 30.83% increase year-on-year, with a net profit of 186 million yuan, up 5.21% [23] New Product Developments - Up Beauty is preparing to launch a new makeup brand called "Dan Cai" in collaboration with a renowned makeup artist [2] - COSMAX announced breakthroughs in anti-aging and whitening products, including a new NAD-based anti-aging cosmetic and a new whitening powder [3] - LV Cosmetics has begun global pre-sales, indicating a strong push into the market [15] Executive Changes - Proya appointed new executives, including Xue Xia as the board secretary and Guo Xiao as the Chief Marketing Officer, both bringing extensive experience in the consumer sector [4] - Givaudan announced a leadership change, with Gilles Andrier stepping down as CEO in March 2026, to be succeeded by Christian Stammkoetter [5] Market Trends - The beauty and skincare market saw sales of 235.23 billion yuan in the first half of 2025, a 10.1% year-on-year increase, with anti-aging products showing a significant growth of 30.3% [24] - The introduction of innovative products and strategic partnerships, such as COSMAX's collaboration with Korea University for climate-proof cosmetics, reflects the industry's adaptability to changing consumer needs [15]

Company Overview - Olaplex Holdings, Inc. is a foundational health and beauty company known for its innovative hair care products designed for professional hairstylists and consumers [3] - The company was founded in 2014 and has revolutionized the prestige hair care market with its Complete Bond Technology™, which protects, strengthens, and relinks hair bonds during and after services [3] - Olaplex offers a full suite of hair health formulas and its award-winning products are sold globally through an omnichannel model, including professional, specialty retail, and direct-to-consumer channels [3] Upcoming Events - Amanda Baldwin, CEO, and Catherine Dunleavy, COO & CFO, will present at the Barclays 18th Annual Global Consumer Staples Conference on September 2, 2025, at 3:45 PM ET [2] - The audio portion of the presentation will be available on the company's Investor Relations website for 90 days following the event [2] Investor Relations - The company has designated contacts for investor relations and financial media, including Michael Oriolo as Vice President of Investor Relations and Lisa Bobroff as Vice President of Global Communications & Consumer Engagement [4]

Core Insights - Olaplex Holdings, Inc. will participate in the Canaccord Genuity 45th Annual Growth Conference in Boston, MA [1] - CEO Amanda Baldwin will host a fireside chat on August 12, 2025, at 8:30 am ET, with investor meetings scheduled throughout the day [2] - The audio of the fireside chat will be available on the Company's Investor Relations website for 90 days post-event [2] Company Overview - Olaplex is a health and beauty company founded in 2014, known for its innovative hair care products [3] - The company revolutionized the prestige hair care market with its Complete Bond Technology™, which protects and strengthens hair during and after services [3] - Olaplex offers a comprehensive range of hair health formulas and sells its award-winning products globally through various channels, including professional, specialty retail, and direct-to-consumer [3]